| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| James Patrick Kelly | EVP CFO and Treasurer | 2026-03-07 | 5,904 | $9.98 | $58.92kSell |
| Elaine Ohara | EVP Chief Strategy Officer | 2026-03-03 | 22,429 | $9.49 | $212.85kSell |
| Mark J. Casey | EVP Chief Legal Officer | 2026-03-03 | 11,378 | $9.49 | $107.98kSell |
| Ruxandra Draghiaakli | EVP Research Development | 2026-03-03 | 11,313 | $9.49 | $107.36kSell |
| Ruxandra Draghiaakli | EVP Research Development | 2026-03-03 | 11,313 | $9.49 | $107.36kSell |
| John C. Jacobs | President and CEO | 2026-03-03 | 69,288 | $9.49 | $657.54kSell |
| James Patrick Kelly | EVP CFO and Treasurer | 2026-03-03 | 20,850 | $9.49 | $197.87kSell |
| Elaine Ohara | EVP Chief Strategy Officer | 2026-03-01 | 10,969 | $10.14 | $111.23kSell |
| John C. Jacobs | President and CEO | 2026-03-01 | 38,450 | $10.14 | $389.88kSell |
| John C. Jacobs | President and CEO | 2026-03-01 | 38,450 | $10.14 | $389.88kSell |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Vanguard Group Inc | 9.49% | 15,470,365 | $148.82M | Institution |
| Shah Capital Management | 8.94% | 14,558,780 | $140.06M | Institution |
| Blackrock Inc | 7.92% | 12,901,549 | $124.11M | Institution |
| State Street Corp | 5.85% | 9,523,646 | $91.62M | Institution |
| Cadila Pharmaceuticals Ltd | 5.83% | 9,500,000 | $91.39M | Insider |
| Bank Of America Corp | 5.09% | 8,290,665 | $79.76M | Institution |
| Sanofi | 4.22% | 6,880,481 | $66.19M | Institution |
| James B. 1. Tananbaum | 3.85% | 6,268,455 | $60.30M | Insider |
| D E Shaw Co Inc | 3.68% | 5,992,798 | $57.65M | Institution |
| Ubs Group Ag | 3.00% | 4,894,284 | $47.08M | Institution |